Clinical Trial Update: China Action on Spine and Hip Status

View source ↗

Summary

A completed clinical trial conducted by Beijing Jishuitan Hospital in China studied osteoporosis, non-alcoholic fatty liver disease, metabolic syndrome, and obe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease
• Obesity
• Osteoporosis

Snippet

Sponsor: Beijing Jishuitan Hospital | Conditions: Osteoporosis, Liver Steatosis | Status: COMPLETED